title: Aminoglycoside binding to Oxytricha nova telomeric DNA.
abstract: Telomeric DNA sequences have been at the center stage of drug design for cancer treatment in recent years. The ability of these DNA structures to form four-stranded nucleic acid structures, called G-quadruplexes, has been perceived as target for inhibiting telomerase activity vital for the longevity of cancer cells. Being highly diverse in structural forms, these G-quadruplexes are subjects of detailed studies of ligand-DNA interactions of different classes, which will pave the way for logical design of more potent ligands in future. The binding of aminoglycosides was investigated with Oxytricha nova quadruplex forming DNA sequence (GGGGTTTTGGGG)(2). Isothermal titration calorimetry (ITC) determined ligand to quadruplex binding ratio shows 1:1 neomycin:quadruplex binding with association constants (K(a)) ∼ 10(5) M(-1) while paromomycin was found to have a 2-fold weaker affinity than neomycin. The CD titration experiments with neomycin resulted in minimal changes in the CD signal. FID assays, performed to determine the minimum concentration required to displace half of the fluorescent probe bound, showed neomycin as the best of the all aminoglycosides studied for quadruplex binding. Initial NMR footprint suggests that ligand-DNA interactions occur in the wide groove of the quadruplex. Computational docking studies also indicate that aminoglycosides bind in the wide groove of the quadruplex.
authors.affiliation: Laboratories of Medicinal Chemistry, Clemson University, Clemson, South Carolina 29634, United States.
authors.forename: Nihar
authors.initials: N
authors.lastname: Ranjan
authors.forename: Katrine F
authors.initials: KF
authors.lastname: Andreasen
authors.forename: Sunil
authors.initials: S
authors.lastname: Kumar
authors.forename: David
authors.initials: D
authors.lastname: Hyde-Volpe
authors.forename: Dev P
authors.initials: DP
authors.lastname: Arya
mesh_terms: D000617:Aminoglycosides / Q000378:metabolism*; D000818:Animals; D001483:Base Sequence; D002151:Calorimetry; D016054:DNA, Protozoan / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism*; D005601:Framycetin / Q000494:pharmacology; D006147:Guanine; D006860:Hydrogen Bonding; D008024:Ligands; D009682:Magnetic Resonance Spectroscopy; D008958:Models, Molecular; D009355:Neomycin / Q000494:pharmacology; D016813:Oxytricha / Q000235:genetics*; D010303:Paromomycin / Q000494:pharmacology; D012271:Ribostamycin / Q000494:pharmacology; D013056:Spectrophotometry, Ultraviolet
chemical_list: D000617:Aminoglycosides; D016054:DNA, Protozoan; D008024:Ligands; D012271:Ribostamycin; D005601:Framycetin; C488396:neamine; D006147:Guanine; D010303:Paromomycin; D009355:Neomycin